Private company

Sands Capital Life Sciences Pulse Fund II, L.P.

Company in the Cayman Islands incorporated in the Cayman Islands. Summary from the record

Last updated Oct 21, 2026.

Overview

HeadquartersE9¹

See how the biggest companies compare on our leaderboards

Corporate structure

Sands Capital Life Sciences Pulse Fund II, L.P. sits at the top of its group. 6 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Sands Capital Life Sciences Pulse Fund II, L.P. E9
- Acrivon Therapeutics, Inc. Stake · Watertown, Massachusetts
- Alamar Biosciences, Inc. Stake · Fremont, California
- Beta Bionics, Inc. Stake · Irvine, California
- DICE Therapeutics, Inc. Stake · South San Francisco, California
- Inhibikase Therapeutics, Inc. Stake · Atlanta, Georgia, United States

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (5 companies). Each entity in the chart links to its source.

Stakes it holds

Sands Capital Life Sciences Pulse Fund II, L.P. has told the SEC it owns more than 5% of 5 companies, latest first (Schedules 13D and 13G).

Acrivon Therapeutics, Inc.SCHEDULE 13G/A Nov 25, 2022 to Aug 13, 2026²
Inhibikase Therapeutics, Inc.SCHEDULE 13G/A Oct 25, 2024 to Aug 13, 2026³
Alamar Biosciences, Inc.SCHEDULE 13D/A Apr 23, 2026 to Jul 7, 2026⁴
Beta Bionics, Inc.SCHEDULE 13G/A Apr 9, 2025 to Aug 13, 2025⁵
DICE Therapeutics, Inc.SC 13D/A Jun 22, 2023⁶

Sources

The numbers on this page point here. Each one links to the record it came from.